Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil
Clinical trial NCT03480243 · COMPLETED
Trial details
- NCT number
- NCT03480243
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2018-08-02
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.